FDA Approves a New Drug for Menopause Hot Flashes (The New York Times, Oct 24, 2025)

Tier 2: Professional organization or credentialed expert guidance
Publisher: The New York Times · Published: October 24, 2025 · Accessed: August 11, 2026

Visit the source ↗

Claims this source supports

• The New York Times reported (Oct 24, 2025) that the FDA approved Lynkuet (elinzanetant, Bayer), a new non-hormonal drug for moderate to severe hot flashes from menopause, with US availability expected from November 2026.
• Per NYT reporting, Lynkuet blocks two neurokinin receptors (NK-1 and NK-3) while Veozah (fezolinetant) blocks one (NK-3), and is taken once daily at bedtime.
• Per NYT reporting, trial data (OASIS program) showed symptom improvement within about one week for some women.